Assignee
SERHAN CHARLES N
11 granted patents·10 pending applications·117 citations·filing 2003–2012
Top patents by PatentIndex Score
21 records- 0196US7294728B2Lipoxin compounds and their use in treating cell proliferative disordersSERHAN CHARLES N·Filed 2005·Granted Nov 13, 2007·15 cites·4 claims
- 0294US8273792B2Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomersSERHAN CHARLES N·Filed 2006·Granted Sep 25, 2012·14 cites·20 claims
- 0392US7053230B2Aspirin-triggered lipid mediatorsSERHAN CHARLES N·Filed 2003·Granted May 30, 2006·39 cites·2 claims
- 0490US8927747B214-hydroxy-docosahexaenoic acid compoundsSERHAN CHARLES N·Filed 2009·Granted Jan 6, 2015·11 cites·10 claims
- 0589US8119691B2Method for treating airway hyper-responsiveness with lipoxin analogsSERHAN CHARLES N·Filed 2005·Granted Feb 21, 2012·12 cites·1 claims
- 0687US9416118B2Docosahexaenoyl ethanolamidesSERHAN CHARLES N·Filed 2012·Granted Aug 16, 2016·6 cites·18 claims
- 0787US9364454B2Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomersSERHAN CHARLES N·Filed 2012·Granted Jun 14, 2016·3 cites·13 claims
- 0883US8569542B2Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthmaSERHAN CHARLES N·Filed 2011·Granted Oct 29, 2013·5 cites·6 claims
- 0978US7132451B2Inhibition of TNF-α-initiated neutrophil responseSERHAN CHARLES N·Filed 2004·Granted Nov 7, 2006·7 cites·9 claims
- 1071US8722654B2Lipoxin analogs as novel inhibitors of angiogenesisSERHAN CHARLES N·Filed 2011·Granted May 13, 2014·1 cites·2 claims
- 1170US10154977B2Anti-inflammatory particlesSERHAN CHARLES N·Filed 2012·Granted Dec 18, 2018·4 cites·10 claims
- 1265US2008081838A1Inhibition of TNF-alpha-Initiated Neutrophil ResponseSERHAN CHARLES N·Filed 2007·Application pending·0 cites
- 1363US2012277311A1Lipoxin compounds and their use in treating cell proliferative disordersSERHAN CHARLES N·Filed 2010·Application pending·0 cites
- 1462US2008312323A1Inhibition of TNF-alpha-Initiated ResponseSERHAN CHARLES N·Filed 2006·Application pending·0 cites
- 1559US2010105772A1Use of novel lipid mediators to inhibit angiogenesisSERHAN CHARLES N·Filed 2009·Application pending·0 cites
- 1659US2008064749A1Lipoxin Analogs as Novel Inhibitors of AngiogenesisSERHAN CHARLES N·Filed 2007·Application pending·0 cites
- 1756US2012149771A1Method for treating airway hyper-responsiveness with lipoxin analogsSERHAN CHARLES N·Filed 2012·Application pending·0 cites
- 1851US2013217771A1Resolvins: bioemplates for novel therapeutic interventionsSERHAN CHARLES N·Filed 2010·Application pending·0 cites
- 1948US2011301239A1Use of novel lipid mediators to inhibit angiogenesisSERHAN CHARLES N·Filed 2009·Application pending·0 cites
- 2042US2006293288A1Use of resolvins to treat gastrointestinal diseasesSERHAN CHARLES N·Filed 2006·Application pending·0 cites
- 2140US2012010286A1Prevention of neutrophil recruitmentSERHAN CHARLES N·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SERHAN CHARLES N files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →